Cowen and Company set a $160.00 price objective on Stryker Corporation (NYSE:SYK) in a report released on Friday. The brokerage currently has a buy rating on the medical technology company’s stock.

Several other equities analysts have also issued reports on the stock. Royal Bank Of Canada reaffirmed a buy rating and issued a $155.00 price target on shares of Stryker Corporation in a report on Monday, October 2nd. SunTrust Banks, Inc. reaffirmed a buy rating and issued a $161.00 price target on shares of Stryker Corporation in a report on Monday, October 2nd. Argus reaffirmed a buy rating and issued a $160.00 price target on shares of Stryker Corporation in a report on Tuesday, August 29th. BidaskClub lowered shares of Stryker Corporation from a buy rating to a hold rating in a report on Saturday, August 26th. Finally, Needham & Company LLC raised shares of Stryker Corporation from an underperform rating to a hold rating in a report on Friday, August 25th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and twelve have assigned a buy rating to the stock. The company presently has a consensus rating of Hold and an average target price of $146.78.

Stryker Corporation (NYSE SYK) opened at 149.00 on Friday. The company has a 50-day moving average price of $142.44 and a 200 day moving average price of $139.99. Stryker Corporation has a 52-week low of $106.48 and a 52-week high of $149.23. The company has a market capitalization of $55.74 billion, a PE ratio of 33.26 and a beta of 0.81.

Stryker Corporation (NYSE:SYK) last released its quarterly earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.51 by $0.02. Stryker Corporation had a net margin of 14.22% and a return on equity of 24.26%. The business had revenue of $3.01 billion for the quarter, compared to analyst estimates of $2.98 billion. During the same period in the previous year, the company earned $1.39 earnings per share. The business’s revenue for the quarter was up 6.1% on a year-over-year basis. Equities research analysts anticipate that Stryker Corporation will post $6.46 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: “Cowen and Company Analysts Give Stryker Corporation (SYK) a $160.00 Price Target” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this report can be read at https://www.thecerbatgem.com/2017/10/09/cowen-and-company-analysts-give-stryker-corporation-syk-a-160-00-price-target.html.

The business also recently announced a quarterly dividend, which will be paid on Tuesday, October 31st. Stockholders of record on Friday, September 29th will be paid a dividend of $0.425 per share. The ex-dividend date of this dividend is Thursday, September 28th. This represents a $1.70 dividend on an annualized basis and a dividend yield of 1.14%. Stryker Corporation’s dividend payout ratio is currently 37.95%.

In other news, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction dated Friday, August 4th. The shares were sold at an average price of $146.36, for a total transaction of $731,800.00. Following the completion of the sale, the insider now owns 88,207 shares of the company’s stock, valued at $12,909,976.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Graham A. Mclean sold 1,124 shares of the business’s stock in a transaction dated Tuesday, August 8th. The stock was sold at an average price of $146.26, for a total transaction of $164,396.24. Following the sale, the insider now directly owns 8,983 shares of the company’s stock, valued at approximately $1,313,853.58. The disclosure for this sale can be found here. Insiders have sold 25,429 shares of company stock valued at $3,686,927 in the last three months. Corporate insiders own 7.40% of the company’s stock.

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Curbstone Financial Management Corp grew its stake in Stryker Corporation by 86.9% during the 3rd quarter. Curbstone Financial Management Corp now owns 3,560 shares of the medical technology company’s stock valued at $506,000 after acquiring an additional 1,655 shares in the last quarter. Intl Fcstone Inc. purchased a new stake in Stryker Corporation during the 2nd quarter valued at about $287,000. Gs Investments Inc. purchased a new stake in Stryker Corporation during the 2nd quarter valued at about $2,555,000. USA Financial Portformulas Corp purchased a new stake in Stryker Corporation during the 2nd quarter valued at about $3,388,000. Finally, Atlantic Trust LLC purchased a new stake in Stryker Corporation during the 2nd quarter valued at about $201,000. 74.13% of the stock is owned by institutional investors.

About Stryker Corporation

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Analyst Recommendations for Stryker Corporation (NYSE:SYK)

Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.